Skip to content

PC Connection

US · CNXN #2683 by market cap Listed 1970
91.98 -0.41 -0.44%
Live - 5344 symbols - heartbeat 250s ago · 2026-10-08 07:58
Pre-market 91.98 0.00%
After-hours 91.98 0.00%
Market cap
2.32B
P/B
2.44
EPS
3.27
Reader sentiment Are you bullish or bearish on CNXN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good
  • Altman Z-Score is 7.21, above the 3.0 "safe zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +2.52% YoY

Margins

Gross margin
18.77%
Operating margin
3.88%
Net margin
2.91%

Key ratios & quality

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Revenue 2.70B2.82B2.59B2.89B3.12B2.85B2.80B2.87B
Gross profit 411.09M451.31M418.81M464.58M526.18M511.74M519.79M539.33M
Selling & admin expenses 324.43M338.64M345.74M340.60M378.10M378.30M395.00M408.70M
Research & development ----------------
Operating profit 86.65M112.68M73.07M103.48M127.48M112.54M104.19M111.43M
Pretax profit 88.66M112.68M73.20M96.52M121.64M113.11M117.49M113.73M
Tax 24.07M30.57M17.43M26.62M32.42M29.84M30.39M30.01M
Net profit 64.59M82.11M55.77M69.91M89.22M83.27M87.10M83.72M
Basic EPS 23233333
Diluted EPS 2.413.102.122.653.373.153.293.27

Balance sheet

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Total current assets 669.18M776.41M858.98M932.41M953.79M1.05B1.17B1.22B
Cash & ST investments 91.70M90.06M95.66M108.31M122.93M297.19M442.61M406.68M
Inventory 119.20M124.67M140.87M206.56M208.68M124.18M95.05M143.57M
Total assets 805.36M937.34M1.02B1.08B1.10B1.19B1.30B1.35B
Total current liabilities 259.80M308.92M342.26M374.63M310.52M327.97M371.21M420.39M
Short-term debt --4.32M3.93M3.42M3.17M1.73M1.81M1.29M
Long-term debt ----------------
Total liabilities 279,452,000.00340,023,000.00379,046,000.00400,910,000.00333,651,000.00347,614,000.00388,364,000.00440,795,000.00
Total equity 525.90M597.31M636.33M682.47M766.18M840.77M910.99M910.13M
Retained earnings 441.01M514.69M562.08M605.77M686.04M760.90M837.47M905.89M

Cash flow

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Operating cash flow 86.84M36.60M36.10M57.75M34.89M197.95M173.87M65.44M
Depreciation & amortization 14.06M13.31M13.60M12.20M11.98M12.65M12.98M11.70M
Free cash flow 65.60M10.95M25.07M47.45M25.81M188.36M166.29M58.05M
Dividends paid -9.12M-8.45M-8.43M-34.60M-8.95M-8.41M-10.53M-15.30M
Stock buybacks / issuance -15.38M-4.48M-10.22M00-5.39M-12.38M-76.27M
Ending cash balance 91.70M90.06M95.66M108.31M122.93M144.95M178.32M193.22M

Returns & efficiency

Line item 2018 2019 2020 2021 2022 2023 2024 2025
ROE % 12.8114.629.0410.6012.3210.369.949.19
ROA % 8.329.425.716.668.177.287.006.32
ROIC % 12.8114.258.8310.4112.1610.289.908.01
5-year avg ROE % 12.3312.7212.0211.8111.8811.3910.4510.48
EBIT margin % 3.474.002.833.343.863.953.723.88
FCF / sales % 2.430.390.971.640.836.615.932.02
Current ratio 2.582.512.512.493.073.203.142.90
Quick ratio 2.082.082.061.912.362.772.842.51
Debt / assets 0.001.561.340.940.740.410.260.13
LT debt / equity --1.731.510.990.650.380.170.05
Interest coverage ----685.07----------
Revenue CAGR (3Y) % 1.601.55-3.832.333.483.24-1.05-2.77
Net income CAGR (3Y) % 11.3219.500.552.672.8114.307.60-2.10
FCF CAGR (3Y) % 53.68-20.4049.40-10.2333.1095.8751.8931.02

✦ Quant Revenue Concentration how this is computed

Diversified
  • Enterprise Solutions is the largest reported line at 43.28% of revenue, across 3 reported segments.
  • No single line clears half of revenue; Business Solutions is next at 40.27%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Enterprise Solutions43.28%
Business Solutions40.27%
Public Sector Solutions16.45%

Quote time 2026-10-08 07:58:36 · For reference only, not investment advice and not tailored to your situation.